Drug Development for Parasite-Induced Diarrheal Diseases

Drug Development for Parasite-Induced Diarrheal Diseases

Drug Development

One of the top four contributors to the global burden of disease is diarrheal infections. Intestinal parasites are major causes of morbidity and mortality associated with diarrheal diseases in both the developed and developing world. Amebiasis is responsible for 50 million cases of invasive disease and 70,000 deaths annually in the world. Giardiasis has an estimated worldwide prevalence of 280 million cases annually. In developed countries, Giardia lamblia infects about 2% of adults and 6-8% of children. The prevalence of G. lamblia infection is generally higher in developing countries, ranging from 3% to 90%. Furthermore, giardial infections contribute substantially to the 2.5 million annual deaths from diarrheal disease

Anjan Debnath , - James H. McKerrow

https://www.frontiersin.org/research-topics/3253/drug-development-for-parasite-induced-diarrheal-diseases

Frontiers Media SA

2017

Baihaqi

Creative Commons

PDF

English

Textbooks